Covered recipient · General Payments record
BRADLEY BLOOM
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$18,105.50
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $806.73 | 38 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $523.70 | 6 |
| ABBVIE INC. | $246.02 | 30 |
| Lilly USA, LLC | $20.86 | 1 |
| Galderma Laboratories, L.P. | $16.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (38)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.22 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338178 | CMS |
| ABBVIE INC. | $2.82 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338180 | CMS |
| ABBVIE INC. | $8.57 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338182 | CMS |
| ABBVIE INC. | $0.90 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338184 | CMS |
| ABBVIE INC. | $14.77 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338186 | CMS |
| ABBVIE INC. | $6.35 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338188 | CMS |
| ABBVIE INC. | $1.09 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338190 | CMS |
| ABBVIE INC. | $0.67 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338192 | CMS |
| ABBVIE INC. | $0.67 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338194 | CMS |
| ABBVIE INC. | $1.09 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338196 | CMS |
| ABBVIE INC. | $14.77 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338198 | CMS |
| ABBVIE INC. | $6.35 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338200 | CMS |
| ABBVIE INC. | $3.11 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338202 | CMS |
| ABBVIE INC. | $17.76 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338204 | CMS |
| ABBVIE INC. | $18.59 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338206 | CMS |
| ABBVIE INC. | $1.88 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338208 | CMS |
| ABBVIE INC. | $0.90 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338210 | CMS |
| ABBVIE INC. | $4.59 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338212 | CMS |
| ABBVIE INC. | $1.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338214 | CMS |
| ABBVIE INC. | $18.94 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338216 | CMS |
| ABBVIE INC. | $17.88 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338218 | CMS |
| ABBVIE INC. | $0.92 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338220 | CMS |
| ABBVIE INC. | $0.92 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338222 | CMS |
| ABBVIE INC. | $17.88 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338224 | CMS |
| ABBVIE INC. | $5.15 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338226 | CMS |
| ABBVIE INC. | $2.82 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338228 | CMS |
| ABBVIE INC. | $13.61 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338230 | CMS |
| ABBVIE INC. | $6.58 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338232 | CMS |
| ABBVIE INC. | $18.92 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338234 | CMS |
| ABBVIE INC. | $21.30 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103338236 | CMS |
| Galderma Laboratories, L.P. | $16.15 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145286949 | CMS |
| Lilly USA, LLC | $20.86 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136019180 | CMS |
| REVANCE THERAPEUTICS, INC. | $434.72 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913000 | CMS |
| REVANCE THERAPEUTICS, INC. | $1.25 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913002 | CMS |
| REVANCE THERAPEUTICS, INC. | $30.23 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913004 | CMS |
| REVANCE THERAPEUTICS, INC. | $30.11 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913006 | CMS |
| REVANCE THERAPEUTICS, INC. | $1.38 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913008 | CMS |
| REVANCE THERAPEUTICS, INC. | $26.01 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913010 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.